"Sugat S. Patel, M.D Louis J. Chorich, M.D Lisa M. Borkowski, M.D Dino D. Klisovic, M.D Kim M. Johnstone, M.D Dominic M. Buzzacco, M.D Vishal S. Parikh, M.D"

During the past decade, Midwest Retina conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Midwest Retina" are "Diabetic Macular Edema" (3 trials), "Neovascular Age-related Macular Degeneration" (1 trials), "Retinopathy of Prematurity" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Midwest Retina" in a lesser frequency.

Most popular intervention types in "Midwest Retina" are "Drug" (6 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (2 trials), "Bevacizumab" (1 trials) and "Intravitreal Ranibizumab 0.5 mg Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Midwest Retina" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Midwest Retina". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Midwest Retina, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Midwest Retina, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".